Renaissance Technologies’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-57,500
| Closed | -$183K | – | 4617 |
|
|
2022
Q2 | $183K | Buy |
57,500
+31,400
| +120% | +$122K | ﹤0.01% | 3685 |
|
|
2022
Q1 | $111K | Sell |
26,100
-9,400
| -26% | -$41K | ﹤0.01% | 3777 |
|
|
2021
Q4 | $165K | Sell |
35,500
-10,336
| -23% | -$43.1K | ﹤0.01% | 3582 |
|
|
2021
Q3 | $183K | Buy |
+45,836
| New | +$182K | ﹤0.01% | 3223 |
|
|
2021
Q2 | – | Sell |
-33,600
| Closed | -$142K | – | 3958 |
|
|
2021
Q1 | $142K | Sell |
33,600
-96,353
| -74% | -$531K | ﹤0.01% | 3194 |
|
|
2020
Q4 | $504K | Buy |
129,953
+118,853
| +1,071% | +$508K | ﹤0.01% | 2812 |
|
|
2020
Q3 | $45K | Sell |
11,100
-194,633
| -95% | -$806K | ﹤0.01% | 3288 |
|
|
2020
Q2 | $876K | Buy |
+205,733
| New | +$1.25M | ﹤0.01% | 2608 |
|
|
2015
Q4 | – | Sell |
-24,898
| Closed | -$692K | – | 3635 |
|
|
2015
Q3 | $692K | Buy |
+24,898
| New | +$785K | ﹤0.01% | 2525 |
|
|
2014
Q2 | – | Sell |
-27,400
| Closed | -$296K | – | 3241 |
|
|
2014
Q1 | $296K | Buy |
+27,400
| New | +$269K | ﹤0.01% | 2527 |
|
Renaissance Technologies's LJPC Position: Q3 2022 in Review
Renaissance Technologies sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 57,500 shares — an estimated $183K sold.
Renaissance Technologies first reported a position in LJPC in Q1 2014 and held it in 10 quarters. The position peaked at $876K in Q2 2020. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Renaissance Technologies reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Renaissance Technologies sold 57,500 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $183K.
- Renaissance Technologies first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 10 quarters.
- Renaissance Technologies's La Jolla Pharmaceutical Company position peaked at $876K in Q2 2020.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.